SynthesisBrain imaging and behavior2026
Associations between olfactory dysfunction and structural MRI findings in Parkinson's disease: a systematic review.
Synthesis in Brain imaging and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olfactory dysfunction is a common and early non-motor symptom of Parkinson's disease (PD). Structural Magnetic Resonance Imaging (MRI) studies have reported changes in olfactory-related brain regions, but findings remain inconsistent. This review synthesizes MRI evidence to clarify neuroanatomical correlates of olfactory dysfunction in PD. We performed a systematic review to find the associations between olfactory dysfunction and structural MRI findings in people with PD. A systematic search in PubMed, Scopus, and Web of Science yielded 20 eligible studies. The eligible studies involved 1,092 patients with PD. Although there were inconsistent regions of interest and types of analysis, we identified structural changes in the olfactory sulcus and bulb, cortical gray matter, hippocampus, parahippocampus, and basal ganglia that are associated with olfactory dysfunction. Olfactory dysfunction in PD is linked to structural changes in primary olfactory, limbic, and cortical regions. These MRI findings may serve as early biomarkers, but standardized, longitudinal studies are needed to confirm their diagnostic or prognostic value.
Indexed as
Identifiers
42423844What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.